FDA to weigh approval of pain pill billed as opioid alternative

The FDA is set to consider approval of an alternative to opioids developed by Vertex Pharmaceuticals, The Washington Post reported Jan. 13. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis